Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Impact of UGT1A1*28 polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial.
Journal: Future oncology (London, England)
Published: May 04, 2026
Treatment of unresectable and resectable stage IV colorectal cancer.
Journal: Clinical advances in hematology & oncology : H&O
Published: November 07, 2024
Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer.
Journal: Biomedicines
Published: March 29, 2024
MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon.
Journal: Frontiers in oncology
Published: February 17, 2024
On societal response to pandemics: linking past experiences to present events.
Journal: Discover social science and health
Published: January 01, 2022
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer.
Journal: Molecular therapy oncolytics
Published: August 31, 2020
COVID-19 and Cancer: Lessons Learnt from a Michigan Hotspot.
Journal: Cancers
Published: August 05, 2020
Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic Pancreatic Adenocarcinoma.
Journal: The American journal of case reports
Published: July 14, 2020
Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer.
Journal: American journal of clinical oncology
Published: April 07, 2020
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.
Journal: Neuroendocrinology
Published: March 11, 2018
Last Updated: 09/26/2026